MCID: ATR005
MIFTS: 48

Atrophic Gastritis

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Atrophic Gastritis

MalaCards integrated aliases for Atrophic Gastritis:

Name: Atrophic Gastritis 12 15
Gastritis, Atrophic 44 73
Gastritis Atrophic 55
Gastric Atrophy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8929
ICD10 33 K29.4
ICD9CM 35 535.1 535.11
MeSH 44 D005757
NCIt 50 C7405

Summaries for Atrophic Gastritis

MalaCards based summary : Atrophic Gastritis, also known as gastritis, atrophic, is related to autoimmune atrophic gastritis and gastric ulcer, and has symptoms including dyspepsia An important gene associated with Atrophic Gastritis is CHGA (Chromogranin A), and among its related pathways/superpathways are Spinal Cord Injury and Interleukin-4 and 13 signaling. The drugs Hydroxocobalamin and Tetracycline have been mentioned in the context of this disorder. Affiliated tissues include testes, thyroid and spleen, and related phenotype is mortality/aging.

Wikipedia : 76 Atrophic gastritis (also known as Type A or Type B Gastritis more specifically)[citation needed] is a... more...

Related Diseases for Atrophic Gastritis

Diseases in the Atrophic Gastritis family:

Autoimmune Atrophic Gastritis

Diseases related to Atrophic Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 144)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 35.0 CHGA GAST
2 gastric ulcer 30.8 CXCL8 GAST IL1B IL1RN
3 gastrinoma 30.3 CHGA GAST SST
4 microinvasive gastric cancer 30.2 CDX2 GAST S100A8
5 esophagitis 30.2 CXCL8 IL1B TP53
6 neuroendocrine tumor 30.2 CHGA GAST SST
7 gastric neuroendocrine neoplasm 30.1 CHGA GAST SST
8 duodenal gastrinoma 30.1 CHGA GAST SST
9 duodenogastric reflux 29.6 GAST SST
10 helicobacter pylori infection 29.3 CXCL8 GAST IL1B IL1RN S100A8 TP53
11 peptic ulcer disease 29.2 CXCL8 GAST GHRL IL1B IL1RN S100A8
12 dyspepsia 29.2 CXCL8 GHRL PGC SST
13 duodenal ulcer 29.1 CXCL8 GAST IL1B IL1RN S100A8 SST
14 gastric cancer 28.6 CDX2 GAST IL1RN RUNX3 S100A8 TP53
15 gastroesophageal reflux 28.4 CDX2 CXCL8 GAST GHRL IL1B TP53
16 gastritis 27.3 ADH7 CDX2 CHGA CXCL8 GAST GHRL
17 gastric adenocarcinoma 26.5 CDX2 CHGA CXCL8 GAST IL1B IL1RN
18 megaloblastic anemia 1 10.9
19 recurrent corneal erosion 10.8 CXCL8 IL1B
20 bagassosis 10.8 CXCL8 IL1B
21 vaginal benign neoplasm 10.7 CDX2 CHGA
22 goblet cell carcinoid 10.7 CHGA GAST
23 vaginal adenoma 10.7 CDX2 CHGA
24 vaginal tubulovillous adenoma 10.7 CDX2 CHGA
25 vulvar vestibulitis syndrome 10.7 IL1B IL1RN
26 pouchitis 10.7 CXCL8 IL1RN
27 gastric cancer, hereditary diffuse 10.6 IL1B IL1RN
28 peptic esophagitis 10.6 CXCL8 IL1B
29 schnitzler syndrome 10.6 IL1B IL1RN
30 aseptic meningitis 10.5 CXCL8 IL1B IL1RN
31 funisitis 10.5 CXCL8 IL1B
32 aggressive periodontitis 10.5 CXCL8 IL1B IL1RN
33 silicosis 10.5 CXCL8 IL1B IL1RN
34 autoinflammation, lipodystrophy, and dermatosis syndrome 10.5 CXCL8 IL1B IL1RN
35 osteomyelitis 10.5 CXCL8 IL1B IL1RN
36 bone inflammation disease 10.5 CXCL8 IL1B IL1RN
37 synovitis 10.5 CXCL8 IL1B IL1RN
38 haemophilus influenzae 10.5 CXCL8 IL1B
39 non-functioning pancreatic endocrine tumor 10.4 CHGA GAST GHRL
40 cerebral artery occlusion 10.4 IL1B IL1RN ODC1
41 opisthorchiasis 10.4 CXCL8 IL1B
42 adenoma of the pancreas 10.4 CHGA SST
43 periodontal disease 10.4 CXCL8 IL1B IL1RN
44 pernicious anemia 10.4
45 postcholecystectomy syndrome 10.4 GAST SST
46 gastrointestinal neuroendocrine tumor 10.4 CHGA SST
47 mucinous ovarian cystadenoma 10.3 CDX2 GAST
48 trypanosomiasis 10.3 CXCL8 IL1B ODC1
49 aging 10.3
50 adenocarcinoma 10.3

Comorbidity relations with Atrophic Gastritis via Phenotypic Disease Network (PDN): (show all 18)


Active Peptic Ulcer Disease Acute Cystitis
Acute Pancreatitis Anxiety
Bronchitis Chronic Myocardial Ischemia
Deficiency Anemia Duodenitis
Dysthymic Disorder Esophagitis
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Iron Deficiency Anemia
Irritable Bowel Syndrome Ischemic Heart Disease
Paralytic Ileus Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Atrophic Gastritis:



Diseases related to Atrophic Gastritis

Symptoms & Phenotypes for Atrophic Gastritis

UMLS symptoms related to Atrophic Gastritis:


dyspepsia

MGI Mouse Phenotypes related to Atrophic Gastritis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.36 GAST IL1B IL1RN ODC1 RUNX3 S100A8

Drugs & Therapeutics for Atrophic Gastritis

Drugs for Atrophic Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 114)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 44475014
2
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
3
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7 4594 9579578
4
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
5
Amphotericin B Approved, Investigational Phase 4 1397-89-3 14956 5280965
6
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
7 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
8
Metronidazole Approved Phase 4,Phase 3 443-48-1 4173
9
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
10
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
13
Polyestradiol phosphate Approved Phase 4 28014-46-2
14
Pectin Approved, Investigational, Vet_approved Phase 4 9000-69-5 441476
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 59-30-3 6037
16
Cyanocobalamin Approved, Nutraceutical Phase 4,Not Applicable 68-19-9 44176380
17
Methylcobalamin Approved, Experimental, Investigational, Nutraceutical Phase 4 13422-55-4
18 Micronutrients Phase 4,Not Applicable
19 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
20 Hematinics Phase 4,Not Applicable
21 Trace Elements Phase 4,Not Applicable
22 Antacids Phase 4,Phase 3,Not Applicable
23 Vitamin B 12 Phase 4,Not Applicable
24 Vitamin B Complex Phase 4,Not Applicable
25 Vitamins Phase 4,Phase 3,Not Applicable
26 Proton Pump Inhibitors Phase 4,Phase 3
27 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
28
Bismuth Phase 4 7440-69-9 16682734 105143
29 Geranylgeranylacetone Phase 4
30 Fluoroquinolones Phase 4
31 Contraceptive Agents Phase 4
32 Contraceptives, Oral Phase 4
33 Contraceptives, Oral, Combined Phase 4
34 Topoisomerase Inhibitors Phase 4
35 Norgestimate, ethinyl estradiol drug combination Phase 4
36 Nucleic Acid Synthesis Inhibitors Phase 4
37 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
38 Estradiol 17 beta-cypionate Phase 4
39 Estradiol 3-benzoate Phase 4
40 Anti-Infective Agents Phase 4,Phase 3,Phase 2
41 Antiparasitic Agents Phase 4,Phase 3,Phase 2
42 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
43 Liposomal amphotericin B Phase 4
44 Vitamin B12 Nutraceutical Phase 4,Not Applicable
45 Folate Nutraceutical Phase 4,Not Applicable
46
Cobalamin Nutraceutical Phase 4,Not Applicable 13408-78-1 6438156
47 Vitamin B9 Nutraceutical Phase 4,Not Applicable
48
Selenium Approved, Investigational, Vet_approved Phase 3 7782-49-2
49
Omeprazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 73590-58-6 4594
50
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516

Interventional clinical trials:

(show top 50) (show all 58)
# Name Status NCT ID Phase Drugs
1 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
2 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
3 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
4 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4 Esomeprazole;Esomeprazole
5 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4 Selbex;Selbex
6 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
7 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
8 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
9 A Study to Evaluate the Efficacy and Safety of DA-5204 Unknown status NCT02282670 Phase 3 DA-5204;Stillen tab.
10 A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Unknown status NCT01813812 Phase 3 DA-6034;Rebamipide 300mg
11 Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia Completed NCT00719420 Phase 3 Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);Clarithromycin, Amoxicillin, Omeprazole
12 A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province Completed NCT00339768 Phase 3 Amoxicillin/omeprazole
13 Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis Completed NCT00996788 Phase 3 Rebamipide
14 Gastric Preparation of Magnetic-controlled Capsule Endoscopy Unknown status NCT02846155 Phase 2 simethicone;simethicone combined with pronase
15 L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde Completed NCT02524262 Phase 2
16 Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer Completed NCT01002443 Phase 2 Helicobacter pylori eradication;placebo
17 Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Recruiting NCT02782949 Phase 2 Curcumin
18 Chemoprevention of Gastric Carcinogenesis Recruiting NCT02794428 Phase 2 Eflornithine
19 YF476 and Type I Gastric Carcinoids Active, not recruiting NCT01339169 Phase 2 YF476
20 YF476 and Type I Gastric Carcinoids (Norway) Terminated NCT01444014 Phase 2 YF476
21 Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study Unknown status NCT02675010 Not Applicable
22 HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome Unknown status NCT01931293 Not Applicable
23 Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk Unknown status NCT02624271 Not Applicable
24 Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy Unknown status NCT02126722
25 Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus Unknown status NCT00155805
26 Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome Unknown status NCT02695186
27 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Unknown status NCT01813994 Not Applicable Arm1: Statin;Arm2: Placebo
28 Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy Unknown status NCT02284802 Not Applicable
29 Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway Unknown status NCT00498134 Not Applicable Triple therapy for H. pylori infection;Cox-2 inhibitor
30 Volatile Markers in Digestive Cancer Unknown status NCT02332213
31 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
32 Grading Atrophic Gastritis by Confocal Laser Endomicroscopy Probe (p-CLE) Completed NCT02351154 Not Applicable
33 Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years Completed NCT01824953
34 Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy Completed NCT02724280
35 New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy Completed NCT02597517
36 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
37 Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis Completed NCT00920712 Not Applicable Weiqi decotion
38 Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) Completed NCT00212225
39 Gastric Microbiota and Helicobacter Pylori Test Findings Completed NCT02542579
40 A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach Completed NCT01132534
41 New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy Completed NCT01896310
42 Optimal Site for Rapid Urease Test in the Stomach Completed NCT02945137
43 Performances of a Fast Test for the Detection of Helicobacter Pylori Antigens in Child Stool Completed NCT03324763
44 Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis Completed NCT02721355 Not Applicable
45 Helicobacter Pylori and Proton Pump Inhibitor Completed NCT02449941 PPI (proton pump inhibitor)
46 Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients Recruiting NCT02691637
47 Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea Recruiting NCT02184910 pepsinogen and gastrin
48 Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation Recruiting NCT03314038
49 Gastropanel for Gastric Atrophy and Cancer Risk Assessment Recruiting NCT02114411
50 Gastric Cancer Screening Quality Improvement System Establishment Recruiting NCT02457624

Search NIH Clinical Center for Atrophic Gastritis

Cochrane evidence based reviews: gastritis, atrophic

Genetic Tests for Atrophic Gastritis

Anatomical Context for Atrophic Gastritis

MalaCards organs/tissues related to Atrophic Gastritis:

41
Testes, Thyroid, Spleen, Liver, Colon, T Cells, Endothelial

Publications for Atrophic Gastritis

Articles related to Atrophic Gastritis:

(show top 50) (show all 648)
# Title Authors Year
1
Impact of SNP-SNP interactions of DNA repair gene<i>ERCC5</i>and metabolic gene<i>GSTP1</i>on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
2
Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. ( 29768385 )
2018
3
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
4
Polymorphism rs7521584 in miRa89429 is associated with the severity of atrophic gastritis in patients with HelicobacterA pylori infection. ( 29956763 )
2018
5
Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. ( 29665437 )
2018
6
Material basis research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats through integration of urinary metabonomics and SystemsDock. ( 29777900 )
2018
7
Extranodal Rosai-Dorfman Disease With Mucosal Involvement of the Stomach in a Background of Autoimmune Atrophic Gastritis. ( 29720012 )
2018
8
Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori. ( 29695148 )
2018
9
Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis. ( 29599609 )
2018
10
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis. ( 29524079 )
2018
11
Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. ( 29865036 )
2018
12
Training Effect on the Inter-observer Agreement in Endoscopic Diagnosis and Grading of Atrophic Gastritis according to Level of Endoscopic Experience. ( 29629520 )
2018
13
Hierarchical and Complex System Entropy Clustering Analysis Based Validation for Traditional Chinese Medicine Syndrome Patterns of Chronic Atrophic Gastritis. ( 29565647 )
2018
14
Helicobacter pylori Eradication Therapy Ameliorates Latent Digestive Symptoms in Chronic Atrophic Gastritis. ( 29587295 )
2018
15
Symptomatic Non-acidic Reflux in a Patient With Chronic Autoimmune Atrophic Gastritis Successfully Treated With Anti-reflux Surgery. ( 29291616 )
2018
16
Unusual association between erythema nodosum and autoimmune atrophic gastritis. ( 29545439 )
2018
17
Treatment of <i>Helicobacter pylori</i> infection in atrophic gastritis. ( 29904244 )
2018
18
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. ( 29193217 )
2018
19
Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. ( 29911441 )
2018
20
Infection of <i>Helicobacter pylori</i> and Atrophic Gastritis Influence <i>Lactobacillus</i> in Gut Microbiota in a Japanese Population. ( 29681906 )
2018
21
A case of Metaplastic atrophic gastritis in immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome. ( 29907148 )
2018
22
NMR-based metabolomics Reveals Alterations of Electro-acupuncture Stimulations on Chronic Atrophic Gastritis Rats. ( 28358020 )
2017
23
Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies. ( 28816977 )
2017
24
Editorial: the non-invasive diagnosis of atrophic gastritis. ( 29105139 )
2017
25
Autoimmune atrophic gastritis: current perspectives. ( 28223833 )
2017
26
An Atypical Presentation of Chronic Atrophic Gastritis: Hemolytic Anemia and Mesenteric Panniculitis. ( 28758037 )
2017
27
Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk. ( 28562347 )
2017
28
The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. ( 28728545 )
2017
29
Severe upper gastrointestinal bleeding determined by a gastric lymphoma associated with Helicobacter pylori-positive atrophic gastritis. ( 28730251 )
2017
30
Long non-coding RNA polymorphisms in 6p21.1 are associated with atrophic gastritis risk and gastric cancer prognosis. ( 29221129 )
2017
31
Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. ( 28782119 )
2017
32
The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. ( 28738092 )
2017
33
Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. ( 28662697 )
2017
34
CHINESE HERBAL DECOCTION AS A COMPLEMENTARY THERAPY FOR ATROPHIC GASTRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. ( 28638893 )
2017
35
Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection. ( 28918609 )
2017
36
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. ( 28049442 )
2017
37
The relationship of interpersonal sensitivity and depression among patients with chronic atrophic gastritis: The mediating role of coping styles. ( 29052273 )
2017
38
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. ( 27806647 )
2017
39
High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia. ( 28341758 )
2017
40
MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. ( 28150722 )
2017
41
Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50A years: A cross-sectional study. ( 29034535 )
2017
42
Gastric neuroendocrine tumor with hypergastrinemia following type B chronic atrophic gastritis: a case report. ( 28163290 )
2017
43
Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis. ( 28405320 )
2017
44
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. ( 28487082 )
2017
45
Associations of Helicobacter pylori infection and chronic atrophic gastritis with accelerated epigenetic ageing in older adults. ( 28898235 )
2017
46
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis-Authors' reply. ( 29105133 )
2017
47
Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG). ( 29084954 )
2017
48
Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis. ( 28337217 )
2017
49
NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis. ( 27697573 )
2017
50
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer. ( 28465717 )
2017

Variations for Atrophic Gastritis

Expression for Atrophic Gastritis

Search GEO for disease gene expression data for Atrophic Gastritis.

Pathways for Atrophic Gastritis

Pathways related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.58 CXCL8 IL1B TP53
2 11.49 CXCL8 IL1B TP53
3 11.36 CXCL8 IL1B TP53
4 11.23 CXCL8 IL1B IL1RN RUNX3 SST
5 10.82 CXCL8 IL1B IL1RN

GO Terms for Atrophic Gastritis

Cellular components related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.61 CHGA CXCL8 GAST GHRL IL1B IL1RN
2 extracellular region GO:0005576 9.4 ADH7 CHGA CXCL8 GAST GHRL IL1B
3 multivesicular body lumen GO:0097486 9.16 PGA3 PGA5

Biological processes related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.71 CXCL8 IL1B IL1RN TP53
2 regulation of signaling receptor activity GO:0010469 9.63 CXCL8 GAST GHRL IL1B IL1RN SST
3 neutrophil chemotaxis GO:0030593 9.54 CXCL8 IL1B S100A8
4 positive regulation of protein export from nucleus GO:0046827 9.43 IL1B TP53
5 protein catabolic process GO:0030163 9.43 PGA3 PGA5 PGC
6 autophagy GO:0006914 9.35 PGA3 PGA5 PGC S100A8 TP53
7 fever generation GO:0001660 9.32 IL1B IL1RN
8 digestion GO:0007586 8.92 PGA3 PGA5 PGC SST

Molecular functions related to Atrophic Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 interleukin-1 receptor binding GO:0005149 9.16 IL1B IL1RN
2 hormone activity GO:0005179 9.13 GAST GHRL SST
3 aspartic-type endopeptidase activity GO:0004190 8.8 PGA3 PGA5 PGC

Sources for Atrophic Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....